Christopher Palmer has been an associate editor at MDedge News since 2017. When he's not tidying grammar, he writes short pieces about breaking FDA announcements and approvals, as well as journal articles. He proudly holds a BA in English and philosophy. Follow him on Twitter @cmacmpalm.
News
Stillbirth linked to end-stage renal disease
- Author:
- Christopher Palmer
Publish date: March 7, 2020
News
Family history of MI may increase CVD mortality after bilateral salpingo-oophorectomy
- Author:
- Christopher Palmer
Publish date: March 5, 2020
News
China’s health authorities release large coronavirus case series
- Author:
- Christopher Palmer
Publish date: February 25, 2020
News

Neurologists report low job satisfaction
- Author:
- Christopher Palmer
Publish date: February 25, 2020
News

Prescription osteoarthritis relief gets OTC approval
- Author:
- Christopher Palmer
Publish date: February 19, 2020
News

Survey queries pulmonologists' happiness at work
- Author:
- Christopher Palmer
Publish date: February 18, 2020
News

Less than a quarter of endocrinologists happy at work
- Author:
- Christopher Palmer
Publish date: February 18, 2020
News

FDA issues MiniMed600 insulin pump recall
- Author:
- Christopher Palmer
Publish date: February 12, 2020
News

FDA: Cell phones still look safe
- Author:
- Christopher Palmer
Publish date: February 11, 2020
News

Fast-acting, mealtime insulin aspart is approved for kids
- Author:
- Christopher Palmer
Publish date: January 6, 2020
News
Intersubject correlation analyses can be used to pinpoint neural patterns in ADHD
- Author:
- Christopher Palmer
Publish date: December 15, 2019
News

FDA authorizes customizable automated glycemic controller
- Author:
- Christopher Palmer
Publish date: December 13, 2019
News
Abnormal gaze processing found in patients with bipolar disorder
- Author:
- Christopher Palmer
Publish date: December 12, 2019
News
Brains of MDD patients show alterations in areas tied to positive emotions
- Author:
- Christopher Palmer
Publish date: December 11, 2019
News

FDA approves infliximab-axxq for numerous indications
- Author:
- Christopher Palmer
Publish date: December 6, 2019